---
title: "Boston & Cambridge VC Firms 2026: Directory Shortlist for Biotech and Tech Founders"
description: "As of July 2026, the Boston–Cambridge funds we cover — General Catalyst, Battery, Third Rock, Atlas, CRV, F-Prime, Spark — plus when ARCH shows up on East Coast biotech caps."
date: 2026-07-25T00:00:00.000Z
tags: ["boston", "cambridge", "venture-capital", "market-analysis", "biotech"]
source: https://venturecapitaltracker.com/boston-cambridge-vc-firms-2026
---

# Boston & Cambridge VC Firms 2026: Directory Shortlist for Biotech and Tech Founders

> As of July 2026, the Boston–Cambridge funds we cover — General Catalyst, Battery, Third Rock, Atlas, CRV, F-Prime, Spark — plus when ARCH shows up on East Coast biotech caps.

**Short answer (as of July 2026):** For Boston–Cambridge fundraising, the firms we cover with full `/fund/` profiles are [General Catalyst](/fund/general-catalyst) (Cambridge HQ), [Battery Ventures](/fund/battery-ventures) (Boston), [Third Rock Ventures](/fund/third-rock-ventures) (Boston biotech creation), [Atlas Venture](/fund/atlas-venture) (Cambridge biotech creation), [CRV](/fund/crv) (Cambridge early-stage tech), [F-Prime Capital](/fund/f-prime-capital) (Cambridge life sciences / healthtech), and [Spark Capital](/fund/spark-capital) (NY + Boston). [ARCH Venture Partners](/fund/arch-venture-partners) is Chicago-based — mention it when your biotech syndicate looks national, not as a local HQ shop.

This hub is a **directory shortlist**, not a market-size essay. For 2025–2026 Boston dollar flows and sector themes, read the [Boston VC biotech dominance playbook](/2026-boston-vc-2026-biotech-dominance-playbook). For companies mapped to this ecosystem, see [Boston–Cambridge startups we cover](/boston-cambridge-startups-we-cover-2026). Browse all funds in the [directory](/directory).

### Firm table: stage, thesis, profile

| Firm | HQ (directory) | Stage signal (directory) | Thesis / when to pitch | Profile |
|---|---|---|---|---|
| [General Catalyst](/fund/general-catalyst) | Cambridge, MA | Leads Series A / B+; invests seed → growth | Multi-stage AI, health, fintech, enterprise — full-stack platform, not biotech-only | [/fund/general-catalyst](/fund/general-catalyst) |
| [Battery Ventures](/fund/battery-ventures) | Boston, MA | Leads Series A / B+; invests seed → growth | Application software, infrastructure, consumer, industrial tech — Boston-founded since 1983 | [/fund/battery-ventures](/fund/battery-ventures) |
| [Third Rock Ventures](/fund/third-rock-ventures) | Boston, MA | Leads seed / Series A | Company-creation therapeutics — partners co-found with scientists | [/fund/third-rock-ventures](/fund/third-rock-ventures) |
| [Atlas Venture](/fund/atlas-venture) | Cambridge, MA | Leads seed / Series A | Early biotech creation from formation through Series A | [/fund/atlas-venture](/fund/atlas-venture) |
| [CRV](/fund/crv) | Cambridge, MA | Leads pre-seed / seed / Series A | Early software and tech (DoorDash seed history; Mercury / Vercel-class A’s) | [/fund/crv](/fund/crv) |
| [F-Prime Capital](/fund/f-prime-capital) | Cambridge, MA | Leads Series A / B+; invests from seed | Life sciences, healthtech, plus selective enterprise / frontier — Fidelity-affiliated | [/fund/f-prime-capital](/fund/f-prime-capital) |
| [Spark Capital](/fund/spark-capital) | New York, NY & Boston, MA | Leads Series A / B+; invests seed → growth | Consumer + enterprise (Twitter, Slack, Discord, Coinbase vintage) — dual-city access | [/fund/spark-capital](/fund/spark-capital) |
| [ARCH Venture Partners](/fund/arch-venture-partners) *(optional)* | Chicago, IL | Leads seed / Series A; invests through B+ | Deep-science biotech co-creation — relevant on Boston caps, **not** a Cambridge HQ | [/fund/arch-venture-partners](/fund/arch-venture-partners) |

We do **not** invent AUM, DPI, IRR, or firm check sizes here. Where a fund’s JSON lists `aum: N/A` or omits a ticket, treat check size as **undisclosed** and ask the partner.

### How founders should use this list

1. **Pick the process type.** Third Rock and Atlas often *build* companies; CRV, Battery, Spark, and General Catalyst more often *join* a classic raise. Do not send the same deck narrative to both models.
2. **Match sector honestly.** Therapeutics and platform biology → Third Rock, Atlas, F-Prime (± ARCH). Enterprise / infra / industrial → Battery, CRV, Spark, GC. Health + applied AI can sit in GC or F-Prime depending on clinical vs. software risk.
3. **Use Spark as NY+Boston, not “Boston-only.”** If your buyers and talent are East Coast software, Spark is in-scope; if you need Kendall Square wet-lab company creation, prioritize Atlas / Third Rock.
4. **Cross-check portfolio reality.** After shortlisting funds, open [startups we cover in Boston–Cambridge](/boston-cambridge-startups-we-cover-2026) and the [Boston Metal industrial climate note](/2026-boston-metal-75m-industrial-climate-tech) for a hard-tech example outside pure biotech.
5. **Stay honest about coverage gaps.** Flagship, RA Capital, Underscore, Pillar, and others appear in the [biotech playbook](/2026-boston-vc-2026-biotech-dominance-playbook) editorial list but do **not** all have `/fund/` pages here — do not treat this table as the full Boston phone book.

### Biotech vs. tech split (practical)

| If you are raising for… | First calls from this directory | Secondary / national |
|---|---|---|
| Seed–A therapeutics creation | Third Rock, Atlas, F-Prime | ARCH (Chicago), later GC if platform becomes multi-stage |
| Seed–A enterprise / SaaS / infra | CRV, Battery, Spark, General Catalyst | Multi-stage Bay Area firms outside this hub |
| Healthtech / digital care (software-led) | General Catalyst, F-Prime, Spark | Battery when GTM looks enterprise |
| Industrial / climate hard tech | Battery, General Catalyst | Specialist climate LPs (not all on this list) |

### What this page is not

- Not a 2025 fundraising totals report — that lives in the [Boston biotech dominance playbook](/2026-boston-vc-2026-biotech-dominance-playbook).
- Not an AUM ranking — we refuse fake precision when directory AUM is `N/A`.
- Not every Kendall Square seed fund — only firms in our whitelist with live fund JSON.

### Next steps

- Company map: [Boston–Cambridge startups we cover (2026)](/boston-cambridge-startups-we-cover-2026)
- Market context: [Boston VC biotech dominance playbook](/2026-boston-vc-2026-biotech-dominance-playbook)
- Hard-tech case: [Boston Metal $75M](/2026-boston-metal-75m-industrial-climate-tech)
- Full fund browser: [/directory](/directory)
- East Coast frame: [East Coast venture capital firms 2026](/east-coast-venture-capital-firms-2026)

### Sources

1. Venture Capital Tracker fund profiles: [/fund/general-catalyst](/fund/general-catalyst), [/fund/battery-ventures](/fund/battery-ventures), [/fund/third-rock-ventures](/fund/third-rock-ventures), [/fund/atlas-venture](/fund/atlas-venture), [/fund/crv](/fund/crv), [/fund/f-prime-capital](/fund/f-prime-capital), [/fund/spark-capital](/fund/spark-capital), [/fund/arch-venture-partners](/fund/arch-venture-partners)
2. [Boston VC in 2026 biotech dominance playbook](/2026-boston-vc-2026-biotech-dominance-playbook) (ecosystem dollars / themes)
3. Firm public sites linked from directory JSON (`generalcatalyst.com`, `battery.com`, `thirdrockventures.com`, `atlasventure.com`, `crv.com`, `fprimecapital.com`, `sparkcapital.com`, `archventure.com`)